Does anybody have any insight on SVB Leerink (formerly Leerink Partners)? They're coming to my school next week for 2020 SA recruiting and doesn't seem to be much info out there about them.
| +121 | I think I’m logging off after ER visit | 24 | 19m |
| +109 | AI Creating More Work | 36 | 26m |
| +103 | Is it Bad That I ALREADY Don’t Care? | 31 | 9h |
| +94 | Senior Banker's Guide to IB Recruiting / Group Placement (with a Healthcare Bent) | 10 | 14h |
| +74 | Shit PWP Culture | 53 | 32m |
| +59 | Consulting Son or CorpDev Daughter? | 6 | 4d |
| +44 | How easy was recruiting for you? | 21 | 5d |
| +36 | 22yo IB Analyst just had mental health breakdown | 11 | 1d |
| +26 | Is the life of a VP at a 'top-bank' really good? | 6 | 21h |
| +22 | Law school instead of MBA for RX Banking | 3 | 2d |
Career Resources
Get instant access to lessons taught by experienced private equity pros and bulge bracket investment bankers including financial statement modeling, DCF, M&A, LBO, Comps and Excel Modeling.
Hi UgEcon, hope I can help. Do any of these links cover what you're looking for:
Fingers crossed that one of those helps you.
bump
Healthcare focus, reasonably decent name, I'd put it on par with Cain brothers. No clue how the SVB acquisition will affect them.
Just came to my school. All healthcare focused, lean deal teams. Have boston, charlotte, sf, and ny (99% sure) offices. Seemed professional with respectable deal flow in HC
Have first round interview with them on Friday. Target school for them.
More than healthcare focused, they are biotech and pharma focused specifically. They tend to focus around the middle market of pharma (emerging companies with a couple of promising assets buying each other up etc). US focused for now, and the SVB could potentially bring some of their business to Europe (SVB has a London office) to try and take some share away from the current European names (BBs, Rothschild and biotech boutiques like Ferghana Partners).
Overall, a good bank and better deals than banks like Cain Brothers. They also compete in some slightly different sectors; they do a lot of M&A whilst pharma focused boutiques like HC Wainwright do a lot of underwriting or book running for fund raising.
Bump - how are exits/comp at Leerink? Any idea if there are routes besides healthcare mm pe or corp dev?
Anyone hear back from Leerink's NYC Superday last friday?
can confirm i know someone who has an offer for sa20 (SVB Leerink)
From the interview last Friday? Any idea how the other decisions are going to released?
Can confirm as well. Offers went out right after the Superday.
Really solid name in healthcare coverage, particularly in the Boston market. Had the pleasure of meeting Rob Leerink, and granted he's the capital markets guy of the team, he's incredibly knowledgeable and gives off the impression they run a tight ship there. I also know personally of at least 1 ex-Leerink analyst who has made the transition to GS HC (a cursory linkedin check will confirm.)
They're really strong. Top player in the life sciences space.
Are they having another set of interviews / Superday sometime soon, or is recruiting over?
Nope recruitment is over afaik
Soluta tempora et nihil accusantium. Sint placeat debitis et est recusandae eum. Quisquam quia ipsa a. Ullam dolorem excepturi aut numquam. Voluptas eligendi quia quaerat rerum odit eius et sed.
Explicabo quibusdam nobis non recusandae. Sit illo molestias non reprehenderit sed harum similique cupiditate. Eveniet harum et assumenda repellendus laborum voluptatem ipsam. Doloribus magnam eos iure non. Necessitatibus quibusdam doloribus quaerat odio.
Tempora enim distinctio beatae quia est. Esse quisquam aliquam dolor temporibus. Et omnis omnis dolores fugiat quod dolorem consequuntur. Similique eligendi reiciendis odit placeat voluptatem. Nobis quis non ut fugiat consequatur. Vel dicta deserunt porro eos voluptas accusamus.
Molestiae voluptatibus in aliquam debitis. Ipsa culpa ex et natus dolorem. Porro quos nihil quis velit qui quaerat esse quis. Magni corrupti sed ullam odit id fugiat eum. Consequatur magnam repellendus deleniti odio tempora perspiciatis natus. Asperiores beatae quos consequuntur. Animi blanditiis praesentium corporis maxime ea maiores.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...